{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:18:44Z","timestamp":1790889524008,"version":"4.1.0"},"reference-count":199,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":335,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1124\/jpet.123.001816","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T13:15:15Z","timestamp":1700226915000},"page":"273-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic"],"prefix":"10.1016","volume":"388","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-9550","authenticated-orcid":false,"given":"Doodipala Samba","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.123.001816_bib1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/10408444.2016.1220916","article-title":"Sarin (GB, O-isopropyl methylphosphonofluoridate) neurotoxicity: critical review","volume":"46","author":"Abou-Donia","year":"2016","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/jpet.123.001816_bib2","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1073\/pnas.1403285111","article-title":"Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors","volume":"111","author":"Abramian","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001816_bib3","doi-asserted-by":"crossref","first-page":"41795","DOI":"10.1074\/jbc.M110.149229","article-title":"Protein kinase C phosphorylation regulates membrane insertion of GABAA receptor subtypes that mediate tonic inhibition","volume":"285","author":"Abramian","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001816_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2014.09.021","article-title":"Modulation of neurosteroid potentiation by protein kinases at synaptic- and extrasynaptic-type GABAA receptors","volume":"88","author":"Adams","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib5","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2007.03.004","article-title":"Mechanisms of neurosteroid interactions with GABA(A) receptors","volume":"116","author":"Akk","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1124\/jpet.123.001816_bib6","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.psyneuen.2009.05.020","article-title":"The influence of the membrane on neurosteroid actions at GABA(A) receptors","volume":"34","author":"Akk","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1124\/jpet.123.001816_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yebeh.2016.12.024","article-title":"The synthetic neuroactive steroid SGE-516 reduces status epilepticus and neuronal cell death in a rat model of soman intoxication","volume":"68","author":"Althaus","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001816_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib9","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302","volume":"351","author":"Apland","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.neuro.2010.05.014","article-title":"Higher susceptibility of the ventral versus the dorsal hippocampus and the posteroventral versus anterodorsal amygdala to soman-induced neuropathology","volume":"31","author":"Apland","year":"2010","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.123.001816_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108298","article-title":"Acetylcholinesterase inhibitors (nerve agents) as weapons of mass destruction: History, mechanisms of action, and medical countermeasures","volume":"181","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib12","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/nyas.13028","article-title":"Long-term neuropathological and behavioral impairments after exposure to nerve agents","volume":"1374","author":"Aroniadou-Anderjaska","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001816_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.02.017","article-title":"Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy","volume":"133","author":"Aroniadou-Anderjaska","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001816_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv Clin Chem"},{"key":"10.1124\/jpet.123.001816_bib15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.neuro.2012.02.002","article-title":"A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation","volume":"33","author":"Banks","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.123.001816_bib16","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroscience.2019.11.020","article-title":"Screening for efficacious anticonvulsants and neuroprotectants in delayed treatment models of organophosphate-induced status epilepticus","volume":"425","author":"Barker","year":"2020","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.123.001816_bib17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0014-2999(89)90077-0","article-title":"Anticonvulsant profile of the progesterone metabolite 5 \u03b1-pregnan-3 \u03b1-ol-20-one","volume":"166","author":"Belelli","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13045","article-title":"Relating neurosteroid modulation of inhibitory neurotransmission to behaviour","volume":"34","author":"Belelli","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/jpet.123.001816_bib900","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.expneurol.2006.04.029","article-title":"Endogenous neurosteroids modulate epileptogenesis in a model of temporal lobe epilepsy.","volume":"201","author":"Biagini","year":"2006","journal-title":"Experimental neurology"},{"key":"10.1124\/jpet.123.001816_bib19a","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eplepsyres.2015.01.001","article-title":"Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).","volume":"111","author":"Bialer","year":"2015","journal-title":"Epilepsy research"},{"key":"10.1124\/jpet.123.001816_bib19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bmcl.2017.11.043","article-title":"Breakthroughs in neuroactive steroid drug discovery","volume":"28","author":"Blanco","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/jpet.123.001816_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13181-017-0636-2","article-title":"Utility of 2-Pyridine Aldoxime Methyl Chloride (2-PAM) for Acute Organophosphate Poisoning: A Systematic Review and Meta-Analysis","volume":"14","author":"Blumenberg","year":"2018","journal-title":"J Med Toxicol"},{"key":"10.1124\/jpet.123.001816_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/biom9120801","article-title":"Cyclodextrins: Emerging Medicines of the New Millennium","volume":"9","author":"Braga","year":"2019","journal-title":"Biomolecules"},{"key":"10.1124\/jpet.123.001816_bib23","doi-asserted-by":"crossref","first-page":"38856","DOI":"10.1074\/jbc.M004910200","article-title":"GABAA receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway","volume":"275","author":"Brandon","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.123.001816_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"issue":"Suppl 7","key":"10.1124\/jpet.123.001816_bib25","first-page":"3055","article-title":"Neuroactive steroid therapy of status epilepticus in epilepsy rats","volume":"49","author":"Briyal","year":"2008","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ana.24295","article-title":"Pediatric super-refractory status epilepticus treated with allopregnanolone","volume":"76","author":"Broomall","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001816_bib28","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0022-3565(24)36511-5","article-title":"Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor","volume":"280","author":"Carter","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001816_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.115.229302","article-title":"Neurosteroid Structure-Activity Relationships for Functional Activation of Extrasynaptic \u03b4GABA(A) Receptors","volume":"357","author":"Carver","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib31","doi-asserted-by":"crossref","first-page":"8070","DOI":"10.1523\/JNEUROSCI.3393-15.2016","article-title":"Zinc Selectively Blocks Neurosteroid-Sensitive Extrasynaptic \u03b4GABAA Receptors in the Hippocampus","volume":"36","author":"Carver","year":"2016","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib32","doi-asserted-by":"crossref","first-page":"14181","DOI":"10.1523\/JNEUROSCI.0596-14.2014","article-title":"Perimenstrual-like hormonal regulation of extrasynaptic \u03b4-containing GABAA receptors mediating tonic inhibition and neurosteroid sensitivity","volume":"34","author":"Carver","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib33","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0140-6736(20)30611-5","article-title":"Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial","volume":"395","author":"Chamberlain","year":"2020","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001816_bib34","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/s41467-018-06361-4","article-title":"Structural basis of neurosteroid anesthetic action on GABAA receptors","volume":"9","author":"Chen","year":"2018","journal-title":"Nat Commun"},{"key":"10.1124\/jpet.123.001816_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.neuro.2012.03.011","article-title":"Organophosphate-induced brain damage: mechanisms, neuropsychiatric and neurological consequences, and potential therapeutic strategies","volume":"33","author":"Chen","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1124\/jpet.123.001816_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.117.244673","article-title":"Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: Therapeutic insights for epilepsy","volume":"364","author":"Chuang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1124\/jpet.117.246660","article-title":"3 \u03b2-Methyl-Neurosteroid Analogs Are Preferential Positive Allosteric Modulators and Direct Activators of Extrasynaptic \u03b4-Subunit \u03b3-Aminobutyric Acid Type A Receptors in the Hippocampus Dentate Gyrus Subfield","volume":"365","author":"Chuang","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib38","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.neuropharm.2018.11.031","article-title":"Zinc reduces antiseizure activity of neurosteroids by selective blockade of extrasynaptic GABA-A receptor-mediated tonic inhibition in the hippocampus","volume":"148","author":"Chuang","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib39","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/jpet.119.261735","article-title":"Isobolographic Analysis of Antiseizure Activity of the GABA Type A Receptor-Modulating Synthetic Neurosteroids Brexanolone and Ganaxolone with Tiagabine and Midazolam","volume":"372","author":"Chuang","year":"2020","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib40","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJMra1705224","article-title":"Toxidrome Recognition in Chemical-Weapons Attacks","volume":"378","author":"Ciottone","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001816_bib41","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.bbadis.2017.02.003","article-title":"Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy","volume":"1863","author":"Clossen","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1124\/jpet.123.001816_bib42","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1002\/jnr.24028","article-title":"Catamenial-like seizure exacerbation in mice with targeted ablation of extrasynaptic \u03b4GABA-a receptors in the brain","volume":"95","author":"Clossen","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.123.001816_bib43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fncir.2013.00171","article-title":"Metabotropic regulation of extrasynaptic GABAA receptors","volume":"7","author":"Connelly","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1124\/jpet.123.001816_bib45","first-page":"94","article-title":"A double-blind study of ganaxolone in the acute treatment of migraine headaches with or without an aura in premenopausal females","volume":"38","author":"Data","year":"1998","journal-title":"Headache"},{"key":"10.1124\/jpet.123.001816_bib46","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.neuro.2012.09.001","article-title":"Exposure to nerve agents: from status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy","volume":"33","author":"de Araujo Furtado","year":"2012","journal-title":"Neurotoxicology"},{"issue":"0 9, Suppl 9","key":"10.1124\/jpet.123.001816_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb","year":"2012","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib48","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ane.12605","article-title":"Refractory and super-refractory status epilepticus in adults: a 9-year cohort study","volume":"135","author":"Delaj","year":"2017","journal-title":"Acta Neurol Scand"},{"key":"10.1124\/jpet.123.001816_bib49A","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0022-3565(25)20630-9","article-title":"Sensitization of gamma-aminobutyric acidA receptors to neuroactive steroids in rats during ethanol withdrawal.","volume":"278","author":"Devaud","year":"1996","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1124\/jpet.123.001816_bib49","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/hmg\/ddh146","article-title":"GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies","volume":"13","author":"Dibbens","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1124\/jpet.123.001816_bib50","doi-asserted-by":"crossref","first-page":"19m12887","DOI":"10.4088\/JCP.19m12887","article-title":"Effects of Open-Label, Adjunctive Ganaxolone on Persistent Depression Despite Adequate Antidepressant Treatment in Postmenopausal Women: A Pilot Study","volume":"81","author":"Dichtel","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/jpet.123.001816_bib51","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat Med"},{"key":"10.1124\/jpet.123.001816_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.121.000994","article-title":"Therapeutic Basis of Generic Substitution of Antiseizure Medications","volume":"381","author":"Elmer","year":"2022","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib53","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/jpet.123.001816_bib54","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1523\/JNEUROSCI.2913-05.2006","article-title":"Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors","volume":"26","author":"Feng","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib55","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1124\/dmd.122.001218","article-title":"Complex Metabolism of the Novel Neurosteroid, Ganaxolone, in Humans: A Unique Challenge for Metabolites in Safety Testing Assessment","volume":"51","author":"Fitch","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.123.001816_bib56","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12974-016-0744-y","article-title":"Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication","volume":"13","author":"Flannery","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1124\/jpet.123.001816_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.seizure.2018.05.021","article-title":"Timing in the treatment of status epilepticus: From basics to the clinic","volume":"68","author":"Ga\u00ednza-Lein","year":"2019","journal-title":"Seizure"},{"key":"10.1124\/jpet.123.001816_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jamaneurol.2017.4382","article-title":"Association of time to treatment with short-term outcomes for pediatric patients with refractory convulsive status epilepticus","volume":"75","author":"Ga\u00ednza-Lein","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1124\/jpet.123.001816_bib59","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.neuroscience.2010.07.037","article-title":"Neurosteroid withdrawal regulates GABA-A receptor \u03b14-subunit expression and seizure susceptibility by activation of progesterone receptor-independent early growth response factor-3 pathway","volume":"170","author":"Gangisetty","year":"2010","journal-title":"Neuroscience"},{"key":"10.1124\/jpet.123.001816_bib60","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0028-3908(99)00190-2","article-title":"Acute and chronic effects of the synthetic neuroactive steroid, ganaxolone, against the convulsive and lethal effects of pentylenetetrazol in seizure-kindled mice: comparison with diazepam and valproate","volume":"39","author":"Gasior","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib62","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/epi.17132","article-title":"Serum neurofilament light as biomarker of seizure-related neuronal injury in status epilepticus","volume":"63","author":"Giovannini","year":"2022","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.toxlet.2013.11.019","article-title":"A systematic review of neurodevelopmental effects of prenatal and postnatal organophosphate pesticide exposure","volume":"230","author":"Gonz\u00e1lez-Alzaga","year":"2014","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.123.001816_bib64","doi-asserted-by":"crossref","first-page":"5511","DOI":"10.1523\/JNEUROSCI.0900-05.2005","article-title":"Status epilepticus increases the intracellular accumulation of GABAA receptors","volume":"25","author":"Goodkin","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.03.019","article-title":"Persistent behavior deficits, neuroinflammation, and oxidative stress in a rat model of acute organophosphate intoxication","volume":"133","author":"Guignet","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1124\/jpet.123.001816_bib66","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0006-8993(84)90299-3","article-title":"Modulation of the GABA receptor complex by a steroid anaesthetic","volume":"323","author":"Harrison","year":"1984","journal-title":"Brain Res"},{"key":"10.1124\/jpet.123.001816_bib67","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0022-5347(25)00332-5","article-title":"Structure-activity relationships for steroid interaction with the gamma-aminobutyric acidA receptor complex","volume":"241","author":"Harrison","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib68","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1007\/s00213-014-3494-5","article-title":"Pharmacological profile of a 17\u03b2-heteroaryl-substituted neuroactive steroid","volume":"231","author":"Hogenkamp","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001816_bib70","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pharmthera.2007.03.011","article-title":"Neurosteroid binding sites on GABA(A) receptors","volume":"116","author":"Hosie","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1124\/jpet.123.001816_bib71","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature05324","article-title":"Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites","volume":"444","author":"Hosie","year":"2006","journal-title":"Nature"},{"key":"10.1124\/jpet.123.001816_bib72","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.bja.2019.04.061","article-title":"Organophosphorus nerve agent poisoning: managing the poisoned patient","volume":"123","author":"Hulse","year":"2019","journal-title":"Br J Anaesth"},{"key":"10.1124\/jpet.123.001816_bib73","unstructured":"Hussain AM, Wu H, Tsai J, Hornik S, MacLeod DA, Smith S (2019) Population pharmacokinetic\/pharmacodynamic modeling of the electroencephalographic effects of ganaxolone in healthy subjects. Abstract presented at: 73rd Annual Meeting of the American Epilepsy Society. Abstract 2.213."},{"key":"10.1124\/jpet.123.001816_bib74","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408444.2020.1787330","article-title":"A national toxicology program systematic review of the evidence for long-term effects after acute exposure to sarin nerve agent","volume":"50","author":"Jett","year":"2020","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/jpet.123.001816_bib76","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.etap.2010.01.006","article-title":"Neurotoxic effects in patients poisoned with organophosphorus pesticides","volume":"29","author":"Jokanovi\u0107","year":"2010","journal-title":"Environ Toxicol Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4196\/kjpp.2014.18.6.517","article-title":"Phasic and Tonic Inhibition are Maintained Respectively by CaMKII and PKA in the Rat Visual Cortex","volume":"18","author":"Joo","year":"2014","journal-title":"Korean J Physiol Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib78","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)02086-7","article-title":"Protective efficacy of neuroactive steroids against cocaine kindled-seizures in mice","volume":"474","author":"Kaminski","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib79","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.0013-9580.2004.04504.x","article-title":"Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice","volume":"45","author":"Kaminski","year":"2004","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib80","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001816_bib81","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.1991.03470050093029","article-title":"Pyridostigmine used as a nerve agent pretreatment under wartime conditions","volume":"266","author":"Keeler","year":"1991","journal-title":"JAMA"},{"key":"10.1124\/jpet.123.001816_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0920-1211(00)00170-4","article-title":"Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial","volume":"42","author":"Kerrigan","year":"2000","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.123.001816_bib83","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1474-4422(22)00077-1","article-title":"Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial","volume":"21","author":"Knight","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1124\/jpet.123.001816_bib84","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0028-3908(96)00021-4","article-title":"Neuroactive steroids protect against pilocarpine- and kainic acid-induced limbic seizures and status epilepticus in mice","volume":"35","author":"Kokate","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib85","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-3565(25)22531-9","article-title":"Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation","volume":"270","author":"Kokate","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib83a","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0022-3565(24)37827-9","article-title":"Lack of anticonvulsant tolerance to the neuroactive steroid pregnanolone in mice.","volume":"287","author":"Kokate","year":"1998","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1124\/jpet.123.001816_bib86","first-page":"433","article-title":"Neurosteroids: a new class of neuromodulators","volume":"31","author":"Kulkarni","year":"1995","journal-title":"Drugs Today (Barc)"},{"key":"10.1124\/jpet.123.001816_bib87","article-title":"Neuroprotective effects of GABAergic agents (diazepam and THDOC) in the rat model of refractory status epilepticus","author":"Kuruba","year":"2011","journal-title":"Soc. Neurosci. Abstr PN338.08"},{"issue":"9 Pt B","key":"10.1124\/jpet.123.001816_bib88","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.bbadis.2018.05.016","article-title":"Benzodiazepine-refractory status epilepticus, neuroinflammation, and interneuron neurodegeneration after acute organophosphate intoxication","volume":"1864","author":"Kuruba","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Suppl 16","key":"10.1124\/jpet.123.001816_bib89","article-title":"A multicenter, open-label trial of ganaxolone in children with PCDH19 epilepsy (P5.236)","volume":"88","author":"Lappalainen Chez","year":"2017","journal-title":"Neurology"},{"key":"10.1124\/jpet.123.001816_bib90","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/14737175.2021.1904895","article-title":"Ganaxolone treatment for epilepsy patients: from pharmacology to place in therapy","volume":"21","author":"Lattanzi","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"10.1124\/jpet.123.001816_bib91","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.3477","article-title":"Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites","volume":"24","author":"Laverty","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/jpet.123.001816_bib92","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/j.1528-1157.2000.tb00324.x","article-title":"Assessment of ganaxolone\u2019s anticonvulsant activity using a randomized, double-blind, presurgical trial design","volume":"41","author":"Laxer","year":"2000","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib94","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s11689-017-9207-8","article-title":"A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome","volume":"9","author":"Ligsay","year":"2017","journal-title":"J Neurodev Disord"},{"key":"10.1124\/jpet.123.001816_bib95","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1528-1157.2000.tb00244.x","article-title":"Effect of ganaxolone on flurothyl seizures in developing rats","volume":"41","author":"Lipt\u00e1kov\u00e1","year":"2000","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.33549\/physiolres.931754","article-title":"Anticonvulsant action of a new analogue of allopregnanolone in immature rats","volume":"59","author":"Mares","year":"2010","journal-title":"Physiol Res"},{"key":"10.1124\/jpet.123.001816_bib97","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1124\/jpet.123.001816_bib98","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s002040050637","article-title":"Comparative evaluation of benzodiazepines for control of soman-induced seizures","volume":"73","author":"McDonough","year":"1999","journal-title":"Arch Toxicol"},{"key":"10.1124\/jpet.123.001816_bib99","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/jpet.123.001816_bib100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem Toxicol"},{"key":"10.1124\/jpet.123.001816_bib101","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1124\/jpet.123.001816_bib28661725","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/epi4.12669","article-title":"The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: A meta-analysis from randomized controlled trials.","volume":"8","author":"Meng","year":"2023","journal-title":"Epilepsia open"},{"key":"10.1124\/jpet.123.001816_bib69","doi-asserted-by":"crossref","first-page":"12905","DOI":"10.1073\/pnas.96.22.12905","article-title":"Attenuated sensitivity to neuroactive steroids in gamma-aminobutyrate type A receptor delta subunit knockout mice","volume":"96","author":"Mihalek","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001816_bib102","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/jpet.123.001816_bib103","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ana.26493","article-title":"Ganaxolone versus Phenobarbital for Neonatal Seizure Management","volume":"92","author":"Miller","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001816_bib104","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neuint.2007.10.007","article-title":"Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease","volume":"52","author":"Mitchell","year":"2008","journal-title":"Neurochem Int"},{"key":"10.1124\/jpet.123.001816_bib105","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1539\/joh.47.299","article-title":"Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack","volume":"47","author":"Miyaki","year":"2005","journal-title":"J Occup Health"},{"key":"10.1124\/jpet.123.001816_bib106","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuropharm.2016.10.010","article-title":"Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism","volume":"113","author":"Modgil","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib107","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1517\/13543784.8.10.1663","article-title":"Ganaxolone: a novel positive allosteric modulator of the GABA(A) receptor complex for the treatment of epilepsy","volume":"8","author":"Monaghan","year":"1999","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/jpet.123.001816_bib108","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1528-1157.1997.tb01486.x","article-title":"Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity","volume":"38","author":"Monaghan","year":"1997","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib109","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.732213","article-title":"Refractory and Super-Refractory Status Epilepticus in Nerve Agent-Poisoned Rats Following Application of Standard Clinical Treatment Guidelines","volume":"15","author":"Morgan","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1124\/jpet.123.001816_bib110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7742(08)60662-5","article-title":"Modulation of amino acid-gated ion channels by protein phosphorylation","volume":"39","author":"Moss","year":"1996","journal-title":"Int Rev Neurobiol"},{"key":"10.1124\/jpet.123.001816_bib112","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib113","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.123.001763","article-title":"Long-term Neuropsychiatric Developmental Defects after Neonatal Organophosphate Exposure: Mitigation by Synthetic Neurosteroids","volume":"388","author":"Neff","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib114","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.nrl.0000252923.04894.53","article-title":"Nerve agents","volume":"13","author":"Newmark","year":"2007","journal-title":"Neurologist"},{"key":"10.1124\/jpet.123.001816_bib115","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/nyas.13147","article-title":"Benzodiazepine-refractory status epilepticus: pathophysiology and principles of treatment","volume":"1378","author":"Niquet","year":"2016","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"10.1124\/jpet.123.001816_bib116","first-page":"S117","article-title":"Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors","volume":"8","author":"Niquet","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1124\/jpet.123.001816_bib117","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1289\/ehp.011091169","article-title":"Effects of sarin on the nervous system in rescue team staff members and police officers 3 years after the Tokyo subway sarin attack","volume":"109","author":"Nishiwaki","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1124\/jpet.123.001816_bib118","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nurt.2006.11.003","article-title":"Ganaxolone","volume":"4","author":"Nohria","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1124\/jpet.123.001816_bib119","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1440-1819.2004.01313.x","article-title":"Post-traumatic stress disorder symptoms in victims of Tokyo subway attack: a 5-year follow-up study","volume":"58","author":"Ohtani","year":"2004","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1124\/jpet.123.001816_bib120","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0196-0644(96)70052-5","article-title":"Report on 640 victims of the Tokyo subway sarin attack","volume":"28","author":"Okumura","year":"1996","journal-title":"Ann Emerg Med"},{"key":"10.1124\/jpet.123.001816_bib121","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1152\/jn.00727.2012","article-title":"Dual mechanisms diminishing tonic GABAA inhibition of dentate gyrus granule cells in Noda epileptic rats","volume":"110","author":"Pandit","year":"2013","journal-title":"J Neurophysiol"},{"key":"10.1124\/jpet.123.001816_bib122","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1528-1167.2007.01182.x","article-title":"Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy","volume":"48","author":"Pieribone","year":"2007","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/jm401577c","article-title":"Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of \u03b3-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone","volume":"57","author":"Qian","year":"2014","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001816_bib125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0378-4347(00)00447-3","article-title":"A high-performance liquid chromatography-tandem mass spectrometric method for the determination of pharmacokinetics of ganaxolone in rat, monkey, dog and human plasma","volume":"751","author":"Ram","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"10.1124\/jpet.123.001816_bib126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1124\/jpet.123.001817","article-title":"Protective Activity of Novel Hydrophilic Synthetic Neurosteroids on Organophosphate Status Epilepticus-induced Chronic Epileptic Seizures, Non-Convulsive Discharges, High-Frequency Oscillations and Electrographic Ictal Biomarkers","volume":"388","author":"Ramakrishnan","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib127","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1007\/s00213-017-4649-y","article-title":"A randomized controlled trial of ganaxolone in posttraumatic stress disorder","volume":"234","author":"Rasmusson","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/jpet.123.001816_bib800","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fendo.2011.00038","article-title":"Role of anticonvulsant and antiepileptogenic neurosteroids in the pathophysiology and treatment of epilepsy.","volume":"2","author":"Reddy","year":"2011","journal-title":"Frontiers in endocrinology"},{"key":"10.1124\/jpet.123.001816_bib128","unstructured":"Reddy (2023) Neurosteroid Compounds and Methods for their Preparation and Use in Treating Central Nervous System Disorders. United States Patent #11542296B2, pp 1\u201375"},{"key":"10.1124\/jpet.123.001816_bib129","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1358\/dot.2002.38.7.820115","article-title":"The clinical potentials of endogenous neurosteroids","volume":"38","author":"Reddy","year":"2002","journal-title":"Drugs Today (Barc)"},{"key":"10.1124\/jpet.123.001816_bib130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-6147(03)00023-3","article-title":"Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?","volume":"24","author":"Reddy","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.123.001816_bib131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1615\/CritRevNeurobiol.v15.i34.20","article-title":"Pharmacology of endogenous neuroactive steroids","volume":"15","author":"Reddy","year":"2003","journal-title":"Crit Rev Neurobiol"},{"key":"10.1124\/jpet.123.001816_bib132","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00001756-200403010-00026","article-title":"Anticonvulsant activity of the testosterone-derived neurosteroid 3alpha-androstanediol","volume":"15","author":"Reddy","year":"2004","journal-title":"Neuroreport"},{"issue":"Suppl 11","key":"10.1124\/jpet.123.001816_bib133","first-page":"126","article-title":"Gender differences in antiseizure sensitivity of neurosteroids in the pilocarpine model of status epilepticus","volume":"50","author":"Reddy","year":"2009","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib134","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog Brain Res"},{"key":"10.1124\/jpet.123.001816_bib135","series-title":"Method of Treating Organophosphate Intoxication.","first-page":"1","author":"Reddy","year":"2015"},{"key":"10.1124\/jpet.123.001816_bib136","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001816_bib137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fncel.2016.00101","article-title":"Catamenial Epilepsy: Discovery of an Extrasynaptic Molecular Mechanism for Targeted Therapy","volume":"10","author":"Reddy","year":"2016","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/jpet.123.001816_bib138","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jnr.23853","article-title":"Sex differences in the anticonvulsant activity of neurosteroids","volume":"95","author":"Reddy","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1124\/jpet.123.001816_bib139","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/bs.vh.2017.12.001","article-title":"GABA-A receptors mediate tonic inhibition and neurosteroid sensitivity in the brain","volume":"107","author":"Reddy","year":"2018","journal-title":"Vitam Horm"},{"key":"10.1124\/jpet.123.001816_bib140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cotox.2019.08.001","article-title":"Mechanism-based novel antidotes for organophosphate neurotoxicity","volume":"14","author":"Reddy","year":"2019","journal-title":"Curr Opin Toxicol"},{"key":"10.1124\/jpet.123.001816_bib141","first-page":"1","article-title":"Method of treating organophosphate intoxication by administration of neurosteroids","author":"Reddy","year":"2019","journal-title":"United States Patent #10172870"},{"key":"10.1124\/jpet.123.001816_bib142","first-page":"5165","article-title":"Clinical Pharmacology and Therapeutics of Antiepileptic Drugs for Treatment of Epilepsy and Seizure Disorders","volume":"13","author":"Reddy","year":"2020","journal-title":"Int J Pharm Sci Nanotech"},{"key":"10.1124\/jpet.123.001816_bib143","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13028","article-title":"Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women","volume":"34","author":"Reddy","year":"2022","journal-title":"J Neuroendocrinology"},{"key":"10.1124\/jpet.123.001816_bib144","article-title":"Neurosteroid compounds and methods for their preparation and use in treating central nervous system disorders","author":"Reddy","year":"2023","journal-title":"U.S. Patent 11,542,296"},{"key":"10.1124\/jpet.123.001816_bib145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1124\/jpet.123.001819","article-title":"Neuroprotectant Activity of Novel Water-Soluble Synthetic Neurosteroids on Organophosphate Intoxication and Status Epilepticus-induced Long-term Neurological Dysfunction, Neurodegeneration and Neuroinflammation","volume":"388","author":"Reddy","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib147","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/cts.12435","article-title":"A Comparative Toxidrome Analysis of Human Organophosphate and Nerve Agent Poisonings Using Social Media","volume":"10","author":"Reddy","year":"2017","journal-title":"Clin Transl Sci"},{"key":"10.1124\/jpet.123.001816_bib148","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.123.001816_bib149","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1124\/jpet.110.169854","article-title":"The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors","volume":"334","author":"Reddy","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0079-6468(08)70059-6","article-title":"Development of neurosteroid-based novel psychotropic drugs","volume":"37","author":"Reddy","year":"2000","journal-title":"Prog Med Chem"},{"key":"10.1124\/jpet.123.001816_bib151","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1523\/JNEUROSCI.4488-10.2011","article-title":"Development and persistence of limbic epileptogenesis are impaired in mice lacking progesterone receptors","volume":"31","author":"Reddy","year":"2011","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib152","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-3565(24)39152-9","article-title":"Enhanced anticonvulsant activity of ganaxolone after neurosteroid withdrawal in a rat model of catamenial epilepsy","volume":"294","author":"Reddy","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib153","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0022-3565(24)39026-3","article-title":"Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself","volume":"295","author":"Reddy","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib154","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1528-1157.2001.10200.x","article-title":"Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy","volume":"42","author":"Reddy","year":"2001","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib155","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1523\/JNEUROSCI.22-09-03795.2002","article-title":"Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility","volume":"22","author":"Reddy","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib156","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eplepsyres.2010.01.009","article-title":"Ganaxolone suppression of behavioral and electrographic seizures in the mouse amygdala kindling model","volume":"89","author":"Reddy","year":"2010","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.123.001816_bib157","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies [Internet]","article-title":"Neurosteroids \u2014 Endogenous Regulators of Seizure Susceptibility and Role in the Treatment of Epilepsy","author":"Reddy","year":"2012"},{"key":"10.1124\/jpet.123.001816_bib158","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1358\/dof.2004.029.03.793135","article-title":"Ganaxolone: A prospective overview","volume":"29","author":"Reddy","year":"2004","journal-title":"Drugs Future"},{"key":"10.1124\/jpet.123.001816_bib159","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/epi.14693","article-title":"Extrasynaptic \u03b3-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures","volume":"60","author":"Reddy","year":"2019","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/jpet.104.065268","article-title":"Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice","volume":"310","author":"Reddy","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib161","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.neuropharm.2010.08.017","article-title":"Disease-modifying activity of progesterone in the hippocampus kindling model of epileptogenesis","volume":"59","author":"Reddy","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib162","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2017.01.030","article-title":"PR-independent neurosteroid regulation of \u03b12-GABA-A receptors in the hippocampus subfields","volume":"1659","author":"Reddy","year":"2017","journal-title":"Brain Res"},{"key":"10.1124\/jpet.123.001816_bib164","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1124\/jpet.112.192377","article-title":"A mouse kindling model of perimenstrual catamenial epilepsy","volume":"341","author":"Reddy","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108571","article-title":"Comparative profile of refractory status epilepticus models following exposure of cholinergic agents pilocarpine, DFP, and soman","volume":"191","author":"Reddy","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1124\/jpet.123.001816_bib166","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/epi.12989","article-title":"Midazolam as an anticonvulsant antidote for organophosphate intoxication--A pharmacotherapeutic appraisal","volume":"56","author":"Reddy","year":"2015","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib167","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/nyas.14431","article-title":"Magnetic resonance imaging analysis of long-term neuropathology after exposure to the nerve agent soman: correlation with histopathology and neurological dysfunction","volume":"1480","author":"Reddy","year":"2020","journal-title":"Ann N Y Acad Sci"},{"key":"10.1124\/jpet.123.001816_bib168","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/epi4.12389","article-title":"Phenobarbital as alternate anticonvulsant for organophosphate-induced benzodiazepine-refractory status epilepticus and neuronal injury","volume":"5","author":"Reddy","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1124\/jpet.123.001816_bib169","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1124\/jpet.114.222075","article-title":"Antiseizure Activity of Midazolam in Mice Lacking \u03b4-Subunit Extrasynaptic GABA(A) Receptors","volume":"353","author":"Reddy","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 6","key":"10.1124\/jpet.123.001816_bib172","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/epi.12289","article-title":"Neuroactive steroids for the treatment of status epilepticus","volume":"54","author":"Rogawski","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib173","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ana.25008","article-title":"Brexanolone as adjunctive therapy in super-refractory status epilepticus","volume":"82","author":"Rosenthal","year":"2017","journal-title":"Ann Neurol"},{"issue":"Suppl 2","key":"10.1124\/jpet.123.001816_bib174","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/epi.14481","article-title":"Place of neurosteroids in the treatment of status epilepticus","volume":"59","author":"Rossetti","year":"2018","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0014-2999(96)00036-2","article-title":"Steroid receptor-mediated effects of neuroactive steroids: characterization of structure-activity relationship","volume":"303","author":"Rupprecht","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"Suppl 1","key":"10.1124\/jpet.123.001816_bib176","first-page":"S141","article-title":"Treatment of status epilepticus: Physiology, pharmacology, and future directions","volume":"8","author":"Sankar","year":"2023","journal-title":"Epilepsia Open"},{"key":"10.1124\/jpet.123.001816_bib177","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1124\/jpet.118.252155","article-title":"Intravenously Administered Ganaxolone Blocks Diazepam-Resistant Lithium-Pilocarpine-Induced Status Epilepticus in Rats: Comparison with Allopregnanolone","volume":"368","author":"Saporito","year":"2019","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib178","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/00039896.1988.9934372","article-title":"Chronic neurological sequelae of acute organophosphate pesticide poisoning","volume":"43","author":"Savage","year":"1988","journal-title":"Arch Environ Health"},{"key":"10.1124\/jpet.123.001816_bib179","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(99)00114-8","article-title":"Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment","volume":"64","author":"Shih","year":"1999","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/jpet.123.001816_bib180","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0041-008X(03)00019-X","article-title":"Control of nerve agent-induced seizures is critical for neuroprotection and survival","volume":"188","author":"Shih","year":"2003","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.123.001816_bib181","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1093\/brain\/awr215","article-title":"The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol","volume":"134","author":"Shorvon","year":"2011","journal-title":"Brain"},{"key":"10.1124\/jpet.123.001816_bib182","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.123.001816_bib183","article-title":"Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience","volume":"20","author":"Singh","year":"2022","journal-title":"Epilepsy Behav Rep"},{"key":"10.1124\/jpet.123.001816_bib184","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.123.001747","article-title":"Sex Differences in Organophosphate Intoxication Model of Benzodiazepine-Refractory Status Epilepticus and Neuronal Damage","volume":"388","author":"Singh","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib185","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1124\/jpet.123.001794","article-title":"A Pediatric Rat Model of Organophosphate-Induced Refractory Status Epilepticus: Characterization of Long-term Epileptic Seizure Activity, Neurological Dysfunction and Neurodegeneration","volume":"388","author":"Singh","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib186","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/ana.410440417","article-title":"Ganaxolone, a selective, high-affinity steroid modulator of the \u03b3-aminobutyric acid-A receptor, exacerbates seizures in animal models of absence","volume":"44","author":"Snead","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001816_bib187","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/epi.13705","article-title":"Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures","volume":"58","author":"Sperling","year":"2017","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib187a","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1152\/jn.01022.2002","article-title":"Reduced inhibition and sensitivity to neurosteroids in hippocampus of mice lacking the GABA(A) receptor delta subunit.","volume":"90","author":"Spigelman","year":"2003","journal-title":"Journal of neurophysiology"},{"key":"10.1124\/jpet.123.001816_bib188","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.123.001816_bib188a","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1124\/jpet.105.092403","article-title":"Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.","volume":"316","author":"St\u00f3rustovu","year":"2006","journal-title":"The Journal of pharmacology and experimental therapeutics"},{"key":"10.1124\/jpet.123.001816_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2023.107112","article-title":"Phase 2, placebo-controlled clinical study of oral ganaxolone in PCDH19-clustering epilepsy","volume":"191","author":"Sullivan","year":"2023","journal-title":"Epilepsy Res"},{"key":"10.1124\/jpet.123.001816_bib49B","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/13556219772516","article-title":"Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam withdrawn mice by the neurosteroid 5\u03b1pregnan-3\u03b1,21-diol-20-one (alloTHDOC).","volume":"2","author":"Tsuda","year":"1997","journal-title":"Addiction biology"},{"key":"10.1124\/jpet.123.001816_bib192","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/jm9605344","article-title":"3 alpha-Hydroxy-3 beta-(phenylethynyl)-5 beta-pregnan-20-ones: synthesis and pharmacological activity of neuroactive steroids with high affinity for GABAA receptors","volume":"40","author":"Upasani","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.123.001816_bib193","first-page":"106","article-title":"Successful allopregnanolone treatment of new onset refractory status peilpeticus (NORSE) syndrome: first in man experience","volume":"54","author":"Vaitkevicius","year":"2013","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib192a","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1111\/epi.17343","article-title":"Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial.","volume":"63","author":"Vaitkevicius","year":"2022","journal-title":"Epilepsia"},{"issue":"Suppl 9","key":"10.1124\/jpet.123.001816_bib194","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1528-1167.2008.01929.x","article-title":"The role of the newer antiepileptic drugs in the treatment of generalized convulsive status epilepticus","volume":"49","author":"Wheless","year":"2008","journal-title":"Epilepsia"},{"issue":"Pt B","key":"10.1124\/jpet.123.001816_bib195","article-title":"Neurobiology of organophosphate-induced seizures","volume":"101","author":"Williamson","year":"2019","journal-title":"Epilepsy Behav"},{"key":"10.1124\/jpet.123.001816_bib196","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1523\/JNEUROSCI.22-05-01541.2002","article-title":"Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit","volume":"22","author":"Wohlfarth","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/jpet.123.001816_bib197","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1124\/jpet.113.203653","article-title":"Estrous cycle regulation of extrasynaptic \u03b4-containing GABA(A) receptor-mediated tonic inhibition and limbic epileptogenesis","volume":"346","author":"Wu","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib198","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-Resistant Seizures and Brain Injury after Acute Intoxication of Diisopropylfluorophosphate, an Organophosphate Pesticide and Surrogate for Nerve Agents","volume":"367","author":"Wu","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.123.001816_bib199","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ana.21024","article-title":"Human brain structural change related to acute single exposure to sarin","volume":"61","author":"Yamasue","year":"2007","journal-title":"Ann Neurol"},{"key":"10.1124\/jpet.123.001816_bib201","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17512433.2018.1386553","article-title":"A resurging boom in new drugs for epilepsy and brain disorders","volume":"11","author":"Younus","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"Suppl 2","key":"10.1124\/jpet.123.001816_bib202","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/epi.13999","article-title":"Intramuscular Allopregnanolone and Ganaxolone in a Mouse Model of Treatment Resistant Status Epilepticus","volume":"59","author":"Zolkowska","year":"2018","journal-title":"Epilepsia"},{"key":"10.1124\/jpet.123.001816_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100196","article-title":"Neurosteroids as novel antidepressants and anxiolytics: GABA-A receptors and beyond","volume":"11","author":"Zorumski","year":"2019","journal-title":"Neurobiol Stress"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524171649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.123.001816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T18:13:42Z","timestamp":1743185622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524171649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":199,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S0022356524171649"],"URL":"https:\/\/doi.org\/10.1124\/jpet.123.001816","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.123.001816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The Author(s)","name":"copyright","label":"Copyright"}]}}